The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
TGF-β type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells
Abstract
The capacities of different transforming growth factor-β (TGF-β) superfamily members to drive epithelial to mesenchymal transdifferentiation of the murine mammary epithelial cell line NMuMG were investigated. TGF-β1, but not activin A or osteogenic protein-1 (OP-1)/bone morphogenetic protein-7 (BMP-7), was able to induce morphological transformation of NMuMG cells as shown by reorganisation of the actin cytoskeleton and relocalisation/downregulation of E-cadherin and β-catenin, an effect that was abrogated by the more general serine/threonine kinase and protein kinase C inhibitor, staurosporine. TGF-β1 bound to TGF-β type I receptor (TβR-I)/ALK-5 and TβR-II, but not to activin type I receptor (ActR-I)/ALK-2. Activin A bound to ActR-IB/ALK-4 and ActR-II, and BMP-7 bound to ActR-I/ALK-2, BMP type I receptor (BMPR-I)/ALK-3, ActR-II and BMPR-II. TGF-β1 and BMP-7 activated the Smad-binding element (SBE)4promoter with equal potency, whereas activin A had no effect. Transfection of constitutively active (CA)-ALK-4 activated the 3TP promoter to the same extent as TGF-β1 and CA-ALK-5 indicating that activin signalling downstream of type I receptors was functional in NMuMG cells. In agreement with this, activin A induced low levels of plasminogen activator inhibitor I expression compared to the high induction by TGF-β1. In contrast to activin A and BMP-7, TGF-β1 strongly induced Smad2 phosphorylation. Consistent with these findings, TGF-β1 induced the nuclear accumulation of Smad2 and/or Smad3. In addition, NMuMG cells transiently infected with adenoviral vectors expressing high level CA-ALK-5 exhibited full transdifferentiation. On the other hand, infections with low level CA-ALK-5, which alone did not result in transdifferentiation, together with Smad2 and Smad4, or with Smad3 and Smad4 led to transdifferentiation. In conclusion, TGF-β1 signals potently and passes the activation threshold to evoke NMuMG cell transdifferentiation. The TGF-β type I receptor (ALK-5) and its effector Smad proteins mediate the epithelial to mesenchymal transition. Activin A does not induce mesenchymal transformation, presumably because the number of activin receptors is limited, while BMP-7-initiated signalling cannot mediate transdifferentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Self-citationMechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
Kingsley, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.2.133 · Cited by 1,933
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4
Nakao, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.17.5353 · Cited by 1,070
Miettinen, P. J., Ebner, R., Lopez, A. R., & Derynck, R. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.6.2021 · Cited by 937
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1991) · Peptide Growth Factors and Their Receptors I · doi:10.1007/978-1-4612-3210-0_8 · Cited by 861
Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., & Saito, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1320 · Cited by 788
FRANZEN, P. (1993) · Cell · doi:10.1016/0092-8674(93)90489-d · Cited by 766
The Transforming Growth Factor-βs
Roberts, A. B., & Sporn, M. B. (1990) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-49295-2_8 · Cited by 746
Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., & Reichmann, E. (1996) · Genes & Development · doi:10.1101/gad.10.19.2462 · Cited by 681
Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80127-0 · Cited by 628
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
Oft, M., Heider, K.-H., & Beug, H. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00533-7 · Cited by 623
Jonk, L. J. C., Itoh, S., Heldin, C.-H., ten Dijke, P., & Kruijer, W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21145 · Cited by 568
Self-citationCharacterization of Type I Receptors for Transforming Growth Factor-β and Activin
ten Dijke, P., Yamashita, H., Ichijo, H., Franzén, P., Laiho, M., Miyazono, K., & Heldin, C.-H. (1994) · Science · doi:10.1126/science.8140412 · Cited by 551
Self-citationCloning and characterization of a human type II receptor for bone morphogenetic proteins.
Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C. H., & Miyazono, K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7632 · Cited by 550
Self-citationA role for Rho in Ras transformation
Qiu, R. G., Chen, J., McCormick, F., & Symons, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11781 · Cited by 533
Labbé, E., Silvestri, C., Hoodless, P. A., Wrana, J. L., & Attisano, L. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80119-7 · Cited by 517
Hogan, B. L. M. (1999) · Cell · doi:10.1016/s0092-8674(00)80562-0 · Cited by 497
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C. H., & Miyazono, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.1.217 · Cited by 496
Self-citationSmads and early developmental signaling by the TGFβ superfamily
Whitman, M. (1998) · Genes & Development · doi:10.1101/gad.12.16.2445 · Cited by 478
Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2
Macı́as-Silva, M., Hoodless, P. A., Tang, S. J., Buchwald, M., & Wrana, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25628 · Cited by 476
Frolik, C. A., Wakefield, L. M., Smith, D. M., & Sporn, M. B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)90612-5 · Cited by 471
Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling
Wennström, S., Hawkins, P., Cooke, F., Hara, K., Yonezawa, K., Kasuga, M., Jackson, T., Claesson-Welsh, L., & Stephens, L. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00087-7 · Cited by 435
Fujii, M., Takeda, K., Imamura, T., Aoki, H., Sampath, T. K., Enomoto, S., Kawabata, M., Kato, M., Ichijo, H., & Miyazono, K. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3801 · Cited by 415
Reversible Inhibition of Mammary Gland Growth by Transforming Growth Factor-β
Silberstein, G. B., & Daniel, C. W. (1987) · Science · doi:10.1126/science.3474783 · Cited by 400
Persson, U., Izumi, H., Souchelnytskyi, S., Itoh, S., Grimsby, S., Engström, U., Heldin, C.-H., Funa, K., & ten Dijke, P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00954-5 · Cited by 398
Self-citationDeterminants of specificity in TGF-β signal transduction
Chen, Y.-G., Hata, A., Lo, R. S., Wotton, D., Shi, Y., Pavletich, N., & Massagué, J. (1998) · Genes & Development · doi:10.1101/gad.12.14.2144 · Cited by 361
Yamashita, H., ten Dijke, P., Franzén, P., Miyazono, K., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32142-7 · Cited by 326
Self-citationCdc42 Regulates Anchorage-Independent Growth and Is Necessary for Ras Transformation
Qiu, R.-G., Abo, A., McCormick, F., & Symons, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3449 · Cited by 311
Robinson, S. D., Silberstein, G. B., Roberts, A. B., Flanders, K. C., & Daniel, C. W. (1991) · Development · doi:10.1242/dev.113.3.867 · Cited by 230
Heine, U. I., Munoz, E. F., Flanders, K. C., Roberts, A. B., & Sporn, M. B. (1990) · Development · doi:10.1242/dev.109.1.29 · Cited by 220
Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors
Chen, Y.-G., & Massagué, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3672 · Cited by 217
Feng, X.-H., & Derynck, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3912 · Cited by 211
Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J., & Balmain, A. (1998) · PubMed · Cited by 185
Seidel-Dugan, C., Meyer, B. E., Thomas, S. M., & Brugge, J. S. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1835 · Cited by 175
TGF-β singaling and cancer: structural and functional consequences of mutations in Smads
Hata, A., Massagué, J., & Shi, Y. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01247-7 · Cited by 161
Epithelial/mesenchymal interactions and branching morphogenesis of the lung
Hogan, B. L. M., & Yingling, J. M. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80121-4 · Cited by 153
Caulı́n, C., Scholl, F. G., Frontelo, P., Gamallo, C., & Quintanilla, M. (1995) · PubMed · Cited by 105
Regulation of actin organisation by TGF-β in H-ras-transformed fibroblasts
Moustakas, A., & Stournaras, C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.8.1169 · Cited by 98
Self-citationPiek, E., Westermark, U., Kastemar, M., Heldin, C., van Zoelen, E. J. J., Nist�r, M., & ten Dijke, P. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990301)80:5<756::aid-ijc21>3.0.co;2-n · Cited by 84
Self-citationOhtsuki, M., & Massagué, J. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.261 · Cited by 79
Shimizu, A., Kato, M., Nakao, A., Imamura, T., ten Dijke, P., Heldin, C., Kawabata, M., Shimada, S., & Miyazono, K. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00174.x · Cited by 73
Self-citationOpposing Effects of Activin A and Follistatin on Developing Skeletal Muscle Cells
Link, B. A., & Nishi, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3575 · Cited by 56
Piek, E., Franzèn, P., Heldin, C., & ten Dijke, P. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199712)173:3<447::aid-jcp17>3.0.co;2-8 · Cited by 25
Self-citationTorii, Y., Hitomi, K., & Tsukagoshi, N. (1996) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229742 · Cited by 23
Cited by
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Metadata
- Authors
- Piek, E., Moustakas, A., Kurisaki, A., Heldin, C.-H., & Dijke, P. T.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1999-12-15
- Volume
- 112
- Issue
- 24
- Pages
- 4557-4568
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2166644606
- Cited by
- 426
- References
- 46
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.